Cutler Group LP Albireo Pharma, Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$21.19 - $31.29 $10,595 - $15,645
-500 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$27.36 - $35.98 $13,680 - $17,990
500 New
500 $0
Q4 2020

Jan 21, 2021
SELL
$31.56 - $42.16 $157,800 - $210,799
-5,000 Closed
0 $0
Q3 2020

Oct 27, 2020
BUY
$23.19 - $41.61 $115,950 - $208,050
5,000 New
5,000 $0

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email